The application process for NMPA registration of medical devices in China is
Category:行业资讯 Date:2024-07-24 16:04:17 Author: Source:
Understanding and following the structured application process for NMPA registration is crucial for successfully obtaining certification and gaining market access for medical devices in China, one of the largest and most dynamic healthcare markets globally.

The application process for NMPA (National Medical Products Administration) registration of medical devices in China involves several detailed steps to ensure compliance with regulatory requirements. Here’s a structured outline of the application process:

Step-by-Step Application Process:

  1. Preparation Phase:

    • Classification Determination: Determine the classification of your medical device according to the Chinese Medical Device Classification Catalog. This classification will determine the specific regulatory pathway and requirements for certification.

    • Technical Documentation Preparation: Compile comprehensive technical documentation required for the application. This includes:

      • Device description and specifications
      • Design drawings and diagrams
      • Risk analysis according to ISO 14971
      • Clinical evaluation reports (if applicable)
      • Biocompatibility testing reports according to ISO 10993
      • Electrical safety and electromagnetic compatibility (EMC) testing reports
      • Quality management system documentation (ISO 13485 compliance)
      • Labeling and Instructions for Use (IFU) in Chinese
      • Device master record (DMR) containing all necessary documents for device manufacture
  2. Submission Phase:

    • Online Application: Submit the application through the China NMPA Online Registration System (CIRS).

    • Document Submission: Upload all required forms and documentation to the CIRS platform. Ensure that all information provided is complete, accurate, and complies with NMPA regulations.

    • Fee Payment: Pay applicable fees related to the certification process. Fees may vary based on the classification and type of medical device.

  3. Review and Evaluation Phase:

    • Initial Review: NMPA conducts an initial review of the submitted documentation to assess compliance with Chinese regulatory standards. This includes evaluation of safety, efficacy, and quality requirements.

    • Technical Queries: NMPA may issue technical queries or requests for additional information during the review process. Promptly respond with comprehensive answers to expedite the review.

    • Testing and Evaluation: Verify that testing and evaluation reports align with Chinese standards. Ensure that testing is conducted in accredited laboratories and meets specified requirements.

  4. On-site Inspection (if applicable):

    • Inspection Arrangement: For higher-risk devices, NMPA may schedule an on-site inspection of manufacturing facilities. This inspection evaluates adherence to quality management practices, production processes, and regulatory requirements.

    • Inspection Outcome: Address any findings or recommendations from the inspection to ensure compliance with NMPA standards.

  5. Decision Phase:

    • Approval Decision: NMPA makes a decision on the application based on the outcome of the technical review, inspection (if applicable), and evaluation of submitted documentation.

    • Certificate Issuance: If the application meets all requirements and is approved, NMPA issues a registration certificate for the medical device. This certificate allows the device to be legally marketed and sold in China.

Important Considerations:

  • Timeline: The entire process can take approximately 6 months to 1 year or longer, depending on the complexity of the device and any additional requirements encountered during the review and evaluation phases.

  • Expert Assistance: Engaging with regulatory consultants or experts familiar with Chinese medical device regulations can help navigate the process effectively, ensuring compliance and timely approval.

  • Post-Market Obligations: After certification, manufacturers must adhere to post-market surveillance requirements, report adverse events, and comply with ongoing regulatory obligations to maintain the NMPA registration.

Contact Us:

Whatsapp or Wechat:+86 15816864648;email address:hito.lin@grzan.cn


1 - 副本(12).jpg